Markets:

Overview

News

Currencies

International

Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

588.36 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about United Therapeutics Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Chips Down, Ackman Up: How Iran, the Fed, and a Viral Post Defined Monday's Market ↗

Today 1:32 EDT

Via Chartmill

Topics Economy

Why United Therapeutics (UTHR) Stock Is Up Today

March 30, 2026

What Happened? Shares of biotechnology company United Therapeutics (NASDAQ:UTHR) jumped 12.7% in the afternoon session after the company announced its TETON-...

Via StockStory

Traders are paying attention to the gapping stocks in Monday's session. ↗

March 30, 2026

Via Chartmill

1 Surging Stock with Impressive Fundamentals and 2 That Underwhelm

March 30, 2026

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements...

Via StockStory

United Therapeutics Corp. (NASDAQ:UTHR) Emerges as a Peter Lynch-Style GARP Candidate ↗

March 28, 2026

Via Chartmill

United Therapeutics Corp (NASDAQ:UTHR) Emerges as a Peter Lynch-Style GARP Candidate ↗

March 04, 2026

Via Chartmill

United Therapeutics Corp. (NASDAQ:UTHR) Reports Record Annual Revenue Despite Q4 Top-Line Miss ↗

February 25, 2026

Via Chartmill

United Therapeutics Corp. (NASDAQ:UTHR) Passes the "Caviar Cruise" Quality Investing Screen ↗

February 12, 2026

Via Chartmill

Therapeutics Stocks Q4 In Review: United Therapeutics (NASDAQ:UTHR) Vs Peers

March 23, 2026

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Via StockStory

Topics Artificial Intelligence

2 Mid-Cap Stocks for Long-Term Investors and 1 We Avoid

March 19, 2026

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...

Via StockStory

1 Cash-Heavy Stock to Target This Week and 2 That Underwhelm

March 18, 2026

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c...

Via StockStory

Topics Firearms

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment ↗

March 16, 2026

Vera Therapeutics develops clinical-stage therapies for serious immunological diseases, with a lead candidate targeting kidney disorders.

Via The Motley Fool

Topics Regulatory Compliance

This Life Sciences Supplier Has Plunged 50% in a Year, but One Fund Bought Up $28 Million More in Stock ↗

March 16, 2026

Avantor delivers laboratory materials and specialized services to biopharma, healthcare, and advanced technology clients worldwide.

Via The Motley Fool

Topics Regulatory Compliance Supply Chain

Winners And Losers Of Q4: Biogen (NASDAQ:BIIB) Vs The Rest Of The Therapeutics Stocks

March 09, 2026

Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season. Over the next ...

Via StockStory

Topics Artificial Intelligence

2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm

February 26, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Why United Therapeutics (UTHR) Shares Are Sliding Today

February 26, 2026

Shares of biotechnology company United Therapeutics (NASDAQ:UTHR) fell 7.2% in the afternoon session after the company reported fourth-quarter financial results that missed revenue expectations,...

Via StockStory

Topics Earnings

The Moonshot Medicine: United Therapeutics Surges on Record Earnings and TreSMI Breakthrough

February 26, 2026

United Therapeutics Corporation (Nasdaq: UTHR) has long been a favorite of biotech investors who value both steady cash flows and visionary "moonshot" projects. On February 25, 2026, the company...

Via Finterra

Topics Earnings Economy Intellectual Property

United Therapeutics (UTHR) Deep Dive: Strong Q4 and the ‘Inhalation Evolution’

February 26, 2026

As of February 26, 2026, United Therapeutics Corporation (NASDAQ: UTHR) stands at a pivotal crossroads in the biotechnology sector. Long recognized as a dominant force in the treatment of pulmonary...

Via Finterra

Topics Artificial Intelligence Economy Intellectual Property

MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ ↗

February 25, 2026

United Therapeutics unveiled a new product called Tresmi, which is “a proprietary drug device formulation of treprostinil into a soft mist inhaler.”

Via Stocktwits

United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates

February 25, 2026

Biotechnology company United Therapeutics (NASDAQ:UTHR) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 7.4% year on year to $790.2 million. Its GAAP profit of $7.70 per share...

Via StockStory

United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For

February 23, 2026

Biotechnology company United Therapeutics (NASDAQ:UTHR) will be reporting earnings this Wednesday before the bell. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

6 Stock Ideas for the Next 5 Years ↗

February 17, 2026

Listen in as Motley Fool co-founder Tom Gardner and Chief Investment Officer Andy Cross talk about stocks!

Via The Motley Fool

Topics Artificial Intelligence

A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack

January 29, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q3, starting with United...

Via StockStory

Topics Artificial Intelligence

$100 Million Exit: Why One Fund Walked Away From a Chinese E-Commerce Stock Up 24% ↗

January 29, 2026

Vipshop Holdings is a major Chinese e-commerce retailer specializing in branded discount sales for value-focused consumers.

Via The Motley Fool

Topics Economy

This Bank Stock Just Saw a $24 Million Fund Sale, but Here's Why It's Still a Top Holding ↗

January 29, 2026

Via The Motley Fool

Topics Credit Cards ETFs

Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR)

January 27, 2026

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at therapeutics stocks, starting with United...

Via StockStory

Topics Artificial Intelligence

3 Market-Beating Stocks to Target This Week

January 15, 2026

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the...

Via StockStory

Topics Credit Cards Supply Chain

Investment Advisor Doubles Down on Insurance Stock, According to Recent SEC Filing ↗

January 15, 2026

This specialty insurer delivers tailored property and casualty coverage for commercial and individual clients across diverse sectors.

Via The Motley Fool

Topics Bonds Regulatory Compliance

Nepsis Bets on CAVA's Future Growth Plan With $2.9 Million Purchase ↗

January 15, 2026

This fast-casual chain pairs Mediterranean dining with grocery retail, leveraging a vertically integrated, multi-channel strategy.

Via The Motley Fool

Topics Regulatory Compliance

2 Cash-Heavy Stocks to Target This Week and 1 We Question

January 11, 2026

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.